12 results on '"Ignasi Figueras-Nart"'
Number of results to display per page
Search Results
2. Nuevos sistemas de clasificación de las queratosis actínicas y el campo de cancerización
- Author
-
R. Fornons-Servent, A. Bauer-Alonso, and Ignasi Figueras-Nart
- Subjects
business.industry ,Medicine ,Dermatology ,business - Published
- 2020
- Full Text
- View/download PDF
3. Definition of Recurrent Chronic Spontaneous Urticaria
- Author
-
E Serra-Baldrich, Xavier García-Navarro, Antonio Guilabert, Gemma Melé-Ninot, Vicente Expósito-Serrano, Ignasi Figueras-Nart, J. Spertino, Isabel Bielsa-Marsol, Laia Curto-Barredo, and Ana Giménez-Arnau
- Subjects
chronic urticaria ,medicine.medical_specialty ,Hardware_MEMORYSTRUCTURES ,Urticaria ,business.industry ,recurrent chronic spontaneous urticaria ,MEDLINE ,Dermatology ,General Medicine ,Omalizumab ,lcsh:RL1-803 ,Chronic Disease ,lcsh:Dermatology ,Medicine ,Humans ,chronic spontaneous urticaria ,Chronic Urticaria ,business ,Urticària ,Chronic urticaria - Abstract
is missing (Short communication)
- Published
- 2020
4. Definition, aims, and implementation of GA [sup] 2 LEN/HAEi Angioedema Centers of Reference and Excellence
- Author
-
Kemal Özyurt, Teresa Caballero, Aharon Kessel, Andrew J. MacGinnitie, Solange Oliveira Rodrigues Valle, Anthony J. Castaldo, Markus Magerl, Regis A. Campos, Adam Reich, Heike Röckmann-Helmbach, R. Y. Meshkova, Mario Sánchez-Borges, Richard G. Gower, Anna Zalewska-Janowska, Daria Fomina, Célia Costa, Allen P. Kaplan, Marc A. Riedl, Naoko Inomata, Avner Reshef, Alejandro Malbrán, Aurélie Du-Thanh, N. Prior, Hilary Longhurst, Margarida Gonçalo, Kiran Godse, Rosana Câmara Agondi, Andreas Kleinheinz, Inmaculada Martinez-Saguer, Mona Al-Ahmad, Thilo Jakob, Luis Felipe Ensina, José Ignacio Larco Sousa, Anna Tagka, Chikako Nishigori, Nicola Wagner, Hye Ryun Kang, Michael Makris, Nicholas Brodszki, Ricardo Dario Zwiener, Jan Nicolay, Alicja Kasperska-Zając, Iris V Medina, Ignacio J. Ansotegui, Marcin Stobiecki, Alejandro Berardi, Danny M. Cohn, Claudio A S Parisi, Angèle Soria, Torsten Zuberbier, Dario O. Josviack, E Serra-Baldrich, Jonathan A. Bernstein, Anette Bygum, Isao Ohsawa, Henriette Farkas, Iman Nasr, Thomas Buttgereit, Jonathan Peter, Carsten Bindslev-Jensen, Paulo Ricardo Criado, Wolfgang Pfützner, Natalia Fili, Silvia Mariel Ferrucci, Petra Staubach, Peter Schmid-Grendelmeier, M. Gotua, Marcus Maurer, Jose Fabiani, Gordon Sussman, A. Marsland, Konrad Bork, Andrea Zanichelli, Simon Francis Thomsen, Isabelle Boccon-Gibod, Mauro Cancian, German D. Ramon, Zuotao Zhao, Nikolaos G. Papadopoulos, Martijn B. A. van Doorn, Andrea Bauer, Kanokvalai Kulthanan, Claudio Fantini, Henrik Balle Boysen, Lilian Varga, Dorota Krasowska, Ana Giménez-Arnau, Werner Aberer, Ivan Cherrez-Ojeda, Roberta F. Criado, Constance H. Katelaris, Martin Metz, Riccardo Asero, Mitja Košnik, Stephen Betschel, M Sendhil Kumaran, Sigurd Broesby-Olsen, Moshe Ben-Shoshan, Rand Arnaout, Regina Treudler, Laurence Bouillet, Natalia Ilina, Maryam Ali Al-Nesf, Emek Kocatürk, Emel Aygören-Pürsün, William R. Lumry, Guillermo Guidos-Fogelbach, Yuxiang Zhi, Mark Gompels, Andac Salman, Christina Weber-Chrysochoou, Michihiro Hide, Young Min Ye, Aslı Gelincik, William B Smith, Timothy J. Craig, Bruce Ritchie, Daniel O. Vázquez, Mojca Bizjak, Atsushi Fukunaga, Ragıp Ertaş, Urs C. Steiner, Faradiba Sarquis Serpa, Farrukh R. Sheikh, Michael Rudenko, Paula J. Busse, Luisa Karla de Paula Arruda, Liangchun Wang, Todor A. Popov, Anete Sevciovic Grumach, Joachim Dissemond, Dorottya Csuka, Ignasi Figueras-Nart, Aleena Banerji, Tıp Fakültesi, Kemal Özyurt / 0000-0002-6913-8310, Vascular Medicine, ACS - Atherosclerosis & ischemic syndromes, Dermatology, Göncü, Özgür Emek Kocatürk (ORCID 0000-0003-2801-0959 & YÖK ID 217219), Maurer, Marcus, Werner, Aberer, Agondi, Rosana, Al-Ahmad, Mona, Al-Nesf, Maryam Ali, Ansotegui, Ignacio, Arnaout, Rand, Arruda, Luisa Karla, Asero, Riccardo, Aygoeren-Puersue, Emel, Banerji, Aleena, Bauer, Andrea, Ben-Shoshan, Moshe, Berardi, Alejandro, Bernstein, Jonathan A, Betschel, Stephen, Bindslev-Jensen, Carsten, Bizjak, Mojca, Boccon-Gibod, Isabelle, Bork, Konrad, Bouillet, Laurence, Boysen, Henrik Balle, Brodszki, Nicholas, Broesby-Olsen, Sigurd, Busse, Paula, Buttgereit, Thomas, Bygum, Anette, Caballero, Teresa, Campos, Regis A., Cancian, Mauro, Cherrez-Ojeda, Ivan, Cohn, Danny M., Costa, Celia, Craig, Timothy, Criado, Paulo Ricardo, Criado, Roberta F., Csuka, Dorottya, Dissemond, Joachim, Du-Thanh, Aurelie, Ensina, Luis Felipe, Ertaş, Ragıp, Fabiani, Jose E., Fantini, Claudio, Farkas, Henriette, Ferrucci, Silvia Mariel, Figueras-Nart, Ignasi, Fili, Natalia L., Fomina, Daria, Fukunaga, Atsushi, Gelincik, Aslı, Gimenez-Arnau, Ana, Godse, Kiran, Gompels, Mark, Goncalo, Margarida, Gotua, Maia, Gower, Richard, Grumach, Anete S, Guidos-Fogelbach, Guillermo, Hide, Michihiro, Ilina, Natalia, Inomata, Naoko, Jakob, Thilo, Josviack, Dario O., Kang, Hye-Ryun, Kaplan, Allen, Kasperska-Zajac, Alicja, Katelaris, Constance, Kessel, Aharon, Kleinheinz, Andreas, Kosnik, Mitja, Krasowska, Dorota, Kulthanan, Kanokvalai, Kumaran, M. Sendhil, Larco Sousa, Jose Ignacio, Longhurst, Hilary J., Lumry, William, MacGinnitie, Andrew, Magerl, Markus, Makris, Michael P., Malbran, Alejandro, Marsland, Alexander, Martinez-Saguer, Inmaculada, Medina, Iris V., Meshkova, Raisa, Metz, Martin, Nasr, Iman, Nicolay, Jan, Nishigori, Chikako V., Nishigori, Chikako, Ohsawa, Isao, Özyurt, Kemal, Papadopoulos, Nikolaos G., Parisi, Claudio A. S., Peter, Jonathan Grant, Pfuetzner, Wolfgang, Popov, Todor, Prior, Nieves, Ramon, German D., Reich, Adam, Reshef, Avner, Riedl, Marc A., Ritchie, Bruce, Rockmann-Helmbach, Heike, Rudenko, Michael, Salman, Andaç, Sanchez-Borges, Mario, Schmid-Grendelmeier, Peter, Serpa, Faradiba S., Serra-Baldrich, Esther, Sheikh, Farrukh R., Smith, William, Soria, Angele, Staubach, Petra, Steiner, Urs C., Stobiecki, Marcin, Sussman, Gordon, Tagka, Anna, Thomsen, Simon Francis, Treudler, Regina, Valle, Solange, van Doorn, Martijn, Varga, Lilian, Vazquez, Daniel O., Wagner, Nicola, Wang, Liangchun, Weber-Chrysochoou, Christina, Ye, Young-Min, Zalewska-Janowska, Anna, Zanichelli, Andrea, Zhao, Zuotao, Zhi, Yuxiang, Zuberbier, Torsten, Zwiener, Ricardo D., Castaldo, Anthony, and School of Medicine
- Subjects
medicine.medical_specialty ,Edema angioneuròtic ,Urticaria ,media_common.quotation_subject ,Immunology ,education ,GA2LEN ,Angioedema ,Center ,Excellence ,Management ,urticaria ,centres of reference and excelence ,immune system diseases ,center ,medicine ,Immunology and Allergy ,Center (algebra and category theory) ,Angioneurotic edema ,skin and connective tissue diseases ,media_common ,udc:616.1 ,business.industry ,angioedema ,humanities ,referenčni centri odličnosti ,Medicine ,Allergy ,Family medicine ,excellence ,medicine.symptom ,business ,Global Allergy and Asthma European Network ,Urticària ,management - Abstract
This document summarizes the aims of GA2 LEN/HAEi Angioedema Centers of Reference and Excellence (ACAREs) and elaborates the requirements that ACAREs must fulfill to become certified. It also provides (see Appendix S1) background information on GA2LEN and HAEi, including HAEi member organizations and regional patient advocates, on why we need an Angioedema Center of Reference and Excellence (ACARE) program and network, and on the accreditation and certification process, governance and funding, and on the interaction with other GA2LEN networks of centers of reference and excellence. The protocols, aims, requirements, and provisions related to becoming a certified CARE are based on (a) the experience of the GA2LEN UCARE network and (b) input from angioedema patients, general practitioners, and angioedema specialists.
- Published
- 2020
- Full Text
- View/download PDF
5. Dermatologic and Dermatopathologic Features of Monogenic Autoinflammatory Diseases
- Author
-
José M. Mascaró, Ignasi Figueras-Nart, José Hernández-Rodríguez, and Xavier Solanich
- Subjects
0301 basic medicine ,Urticaria ,Biopsy ,Autoimmunity ,Dermatitis ,Review ,0302 clinical medicine ,Maculopapular rash ,Immunology and Allergy ,dermatopathology ,Skin ,Skin manifestations ,maculopapular rash ,monogenic autoinflammatory diseases ,Dermatologia ,Inflamació ,clinical dermatology ,Phenotype ,classification ,Dermatopathology ,Symptom Assessment ,medicine.symptom ,Vasculitis ,Urticària ,lcsh:Immunologic diseases. Allergy ,medicine.medical_specialty ,Immunology ,Dermatology ,Autoimmune Diseases ,Diagnosis, Differential ,Lesion ,03 medical and health sciences ,medicine ,Humans ,Genetic Predisposition to Disease ,Genetic Association Studies ,Inflammation ,business.industry ,autoinflammatory diseases ,medicine.disease ,030104 developmental biology ,Cutaneous Involvement ,Subcutaneous nodule ,urticarial rash ,lcsh:RC581-607 ,Panniculitis ,business ,Biomarkers ,030215 immunology - Abstract
Autoinflammatory diseases include disorders with a monogenic cause and also complex conditions associated to polygenic or multifactorial factors. An increased number of both monogenic and polygenic autoinflammatory conditions have been identified during the last years. Although skin manifestations are often predominant in monogenic autoinflammatory diseases, clinical and histopathological information regarding their dermatological involvement is still scarce. Monogenic autoinflammatory diseases with cutaneous expression can be classified based on the predominant lesion: (1) maculopapular rashes or inflammatory plaques; (2) urticarial rashes; (3) pustular, pyogenic or neutrophilic dermatosis-like rashes; (4) panniculitis or subcutaneous nodules; (5) vasculitis or vasculopathy; (6) hyperkeratotic lesions; (7) hyperpigmented lesions; (8) bullous lesions; and (9) aphthous lesions. By using this classification, this review intends to provide clinical and histopathological knowledge about cutaneous involvement in monogenic autoinflammatory diseases.
- Published
- 2019
- Full Text
- View/download PDF
6. Atopic Dermatitis: From Physiopathology to the Clinics
- Author
-
Oscar Palomares-Gracia and Ignasi Figueras-Nart
- Subjects
0301 basic medicine ,medicine.medical_specialty ,business.industry ,InformationSystems_INFORMATIONSTORAGEANDRETRIEVAL ,Atopic dermatitis ,medicine.disease ,Dermatology ,Pathophysiology ,030207 dermatology & venereal diseases ,03 medical and health sciences ,030104 developmental biology ,0302 clinical medicine ,medicine ,business ,GeneralLiterature_REFERENCE(e.g.,dictionaries,encyclopedias,glossaries) - Abstract
Atopic dermatitis is a chronic, pruritic, relapsing inflammatory disease with a complex etiopathogenesis. Alterations of the epidermal barrier function together with a predominantly type 2 altered immune response are responsible for the heterogeneous clinical manifestation. Although pruritic eczematous plaques represent the most frequent phenotype, several others are also characteristic. The diagnostic of the disease relies on clinical aspects, and no complimentary tests are needed. In the literature, we can find a significant number of diagnostic and screening biomarkers; however, severity ones are the most reliable and applicable. Patient-tailored treatment is mandatory, as not all the patients equally respond to the same drugs. The newly released therapies, as well as those under investigation, give hope to AD patients.
- Published
- 2019
7. Treatment of moderate-to-severe atopic dermatitis with dupilumab in real clinical practice: a multicentre, retrospective case series
- Author
-
Joaquín Sastre, Antonio Valero, J.F. Silvestre, Ricardo Ruiz-Villaverde, P. Herranz‐Pinto, José Juan Pereyra-Rodríguez, Laia Curto-Barredo, Leandro Martinez-Pilar, F.J. Ortiz‐de‐Frutos, L. Herraez‐Herrera, Ignasi Figueras-Nart, E Serra-Baldrich, I. Jáuregui‐Presa, J.C. Armario-Hita, and R. Izu‐Belloso
- Subjects
Moderate to severe ,Adult ,Male ,medicine.medical_specialty ,Adolescent ,Dermatology ,Antibodies, Monoclonal, Humanized ,Severity of Illness Index ,Dermatitis, Atopic ,Young Adult ,Quality of life ,Severity of illness ,medicine ,Humans ,Young adult ,Aged ,Retrospective Studies ,business.industry ,Pruritus ,Retrospective cohort study ,Atopic dermatitis ,Middle Aged ,medicine.disease ,Conjunctivitis ,Dupilumab ,Clinical Practice ,Treatment Outcome ,Quality of Life ,Female ,business ,Follow-Up Studies - Published
- 2019
8. Langerhans cell histiocytosis presenting as fingernail changes
- Author
-
Asunción Vicente, Cristina Jou-Muñoz, Julia María Sánchez-Schmidt, Ofelia Cruz-Martinez, Ignasi Figueras-Nart, Veronica Paola Celis-Passini, Maria Antonia González-Ensenyat, and Xavier Bordas-Orpinell
- Subjects
medicine.medical_specialty ,business.industry ,Mortality rate ,Langerhans cell histiocytosis ,Case Report ,Dermatology ,Disease ,Prognostic factors ,medicine.disease ,Multisystem disease ,030207 dermatology & venereal diseases ,03 medical and health sciences ,0302 clinical medicine ,medicine.anatomical_structure ,030220 oncology & carcinogenesis ,Nail (anatomy) ,medicine ,Ungles -- Malalties ,LCH, Langerhans cell histiocytosis ,Nail involvement ,business - Abstract
Langerhans cell histiocytosis (LCH) identifies a spectrum of disorders that are classified according to the organs involved (single- or multi-organ disease) and the presence or absence of organ failure. Patients younger than 2 years with a multisystem disease have a significantly higher mortality rate than older children.1 Nail involvement in LCH is extremely uncommon and rarely reported. To our knowledge, 18 cases have been documented in the literature to date. According to most cases reported, it is thought to indicate a poor prognosis.2, 3, 4, 5, 6 We report the case of a child with nail lesions, which led to a diagnosis of LCH.
- Published
- 2016
- Full Text
- View/download PDF
9. Omalizumab updosing allows disease activity control in patients with refractory chronic spontaneous urticaria
- Author
-
N Lamas-Domenech, M Villar, Xavier Cubiró, E Serra-Baldrich, Vicente Expósito-Serrano, C Baliu-Piqué, Laia Curto-Barredo, Gemma Melé-Ninot, X Duran-Jordà, M. Bonfill-Ortí, J. Spertino, I Bielsa-Marsol, G Aparicio, X García-Navarro, A Álvarez, Ana Giménez-Arnau, M. Vilavella, A. Guilabert, J Garcias-Ladaria, and Ignasi Figueras-Nart
- Subjects
Adult ,medicine.medical_specialty ,Urticaria ,Treatment outcome ,Drug Resistance ,Dermatology ,Omalizumab ,Disease activity ,030207 dermatology & venereal diseases ,03 medical and health sciences ,0302 clinical medicine ,Refractory ,Anti-Allergic Agents ,Medicine ,Humans ,In patient ,Retrospective Studies ,Dose-Response Relationship, Drug ,business.industry ,Urticària -- Tractament ,Age Factors ,Retrospective cohort study ,Middle Aged ,Treatment Outcome ,030228 respiratory system ,Multicenter study ,Chronic Disease ,Female ,business ,medicine.drug - Published
- 2018
10. Actinic Keratosis, a Chronic, Progressive Disease: Understanding Clinical Gaps to Optimise Patient Management
- Author
-
Rino Cerio, Ignasi Figueras Nart, Thomas Dirschka, Giovanni Pellacani, Brigitte Dréno, Andrés Ruiz de Casas, John T. Lear, and Ketty Peris
- Subjects
0301 basic medicine ,030103 biophysics ,medicine.medical_specialty ,Consensus ,Skin Neoplasms ,Keratosis ,Treatment outcome ,MEDLINE ,Dermatology ,Severity of Illness Index ,030207 dermatology & venereal diseases ,03 medical and health sciences ,0302 clinical medicine ,Predictive Value of Tests ,Risk Factors ,Severity of illness ,lcsh:Dermatology ,actinic keratosis ,Medicine ,Humans ,Tumors ,integumentary system ,business.industry ,Actinic keratosis ,General Medicine ,lcsh:RL1-803 ,medicine.disease ,Professional Practice Gaps ,Patient management ,Skin diseases ,Keratosis, Actinic ,Treatment Outcome ,Malalties de la pell ,Predictive value of tests ,Chronic Disease ,Practice Guidelines as Topic ,business ,Settore MED/35 - MALATTIE CUTANEE E VENEREE ,Progressive disease - Abstract
Actinic keratosis (AK) is a chronic, progressive disease of the skin that has undergone long-term sun exposure. The affected areas contain visible and subclinical nonvisible sun damage resulting in epidermal keratinocyte dysplasia, known by many as ‘field cancerisation’ (1), which is prone to AKs and sun-related skin cancer (2). Thus, visible AKs are clinical biomarkers for a photo-damaged field with subclinical damage associated with the unpredictable risk of progression to invasive squamous cell carcinoma (iSCC) (3). The aim of this multiexpert opinion article is to provide a discussion succinctly highlighting the clinical gaps for optimal management of AK: the lack of a universal definition and the need for a standardised grade assessment of AK/field cancerisation that also takes into account individual risk.
- Published
- 2017
11. Escleromixedema
- Author
-
Anna Serra, Sara Gómez Armayones, and Ignasi Figueras Nart
- Subjects
business.industry ,Medicine ,Dermatology ,business - Published
- 2014
- Full Text
- View/download PDF
12. Pioderma gangrenoso
- Author
-
Alba Álvarez-Abella, Ignasi Figueras Nart, Anna Serra, and Sara Martín-Sala
- Subjects
business.industry ,Medicine ,Dermatology ,business - Published
- 2012
- Full Text
- View/download PDF
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.